Zhuhai Hefang Intelligent Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Zhuhai Hefang Intelligent Technology Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HOLFENRY. The owner is based in ZhuHai, Guangdong.

B710B, No. 8 Gangle Road

Tangjiawan Town, High-tech Zone,

ZhuHai, Guangdong 519085 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Zhuhai Hefang Intelligent Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Zhuhai Hefang Intelligent Technology Co., Ltd. have?

Zhuhai Hefang Intelligent Technology Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does Zhuhai Hefang Intelligent Technology Co., Ltd. file in?

Zhuhai Hefang Intelligent Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Zhuhai Hefang Intelligent Technology Co., Ltd.'s most well-known trademarks?

Zhuhai Hefang Intelligent Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as HOLFENRY. These are among 1 currently registered trademark in the portfolio.

What is Zhuhai Hefang Intelligent Technology Co., Ltd.'s trademark registration success rate?

Zhuhai Hefang Intelligent Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.